2018 Exhibitors

Multimodal bioinformatics more accessible to biologists, computer scientists, innovators and everyone in between.

3M Separation and Purification Sciences Division provides cutting edge separation and purification technology and products for biopharmaceutical companies involved in production of recombinant proteins, plasma fractionation products, vaccines and small molecule drugs. Using 3M’s innovative material science platforms, we help companies optimize their processes, improve product safety and increase manufacturing efficiencies, thereby, improving lives everywhere as a trusted supplier of purification

Situated in the Heart of Europe the A&M Laboratory Group offers GxP compliant analytical services “Made in Germany”. With 200+ dedicated scientists and technicians, state-of-the-art equipment and a 25+ year flawless track record in authority and client audits, A&M is your analytical one-stop shop, supporting the development of your drug from development to manufacturing. With clients ranging from single person start-ups to big pharma we could be the ideal partner for your outsourcing needs, too.

Accelera is uniquely placed to provide mainstream pharma capabilities in response to your preclinical needs.
Accelera offers a complete range of toxicology protocols in multiple test species, including NHPs. From acute to chronic, Study Directors with an average of 20 years industrial experience ensure quality performance, interpretation, review and reporting.
Excellence and Expertise in Oncology R&D, including small molecules, biologics, and CARTs. In vivo tumor models. PK/PD. Pharmacology

Aepodia is a solution provider specialised in the early development of drugs and medical devices up to clinical proof-of-concept (from preclinical to Phase 2). Aepodia offers expertise and innovative approaches to optimise the clinical development programmes of products as well as the management and operational execution of clinical studies carried out in multiple countries. With offices in Belgium and France, Aepodia is a recognised partner for pharmaceutical and biotechnology companies.

With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services.
To meet client needs around the world, Alcami fields state-of-the-art facilities at strategic locations in the United States and European Union.

Alira Health is an international advisory firm providing integrated Transaction Services, Strategy and Medical Affairs consulting and contract research to companies in the Life Science industries. We partner with clients to identify the best roadmap for advancement and goal realization. We provide the right financial, scientific, clinical and marketing tools to empower their ideas, implement their strategies and succeed at every turn.

Amylgen is a preclinical CRO offering in vivo models of psychiatric and neurodegenerative diseases. By combining a strong experience in behavior with expertise in biochemistry, neurochemistry and histology, Amylgen offers an integrated service. Your product can be evaluated on multiple aspects of brain function including memory, depression, anxiety.
All behavior effects may be supported by relevant analysis helping the understanding of the mechanism of action on brain health.

Antineo accompanies clients in the preclinical development of novel anticancer agents. We provide strategic advice for preclinical development (choice of indications to focus on etc.), and expertise and in vitro, ex vivo and in vivo services aiming at characterising the mode of action and the anti-tumoral efficacy of new drugs.
We have a strong expertise in immunotherapies, and in the development and characterisation of original models for secondary resistances to gold standards.

Established in 1993, Apollo Scientific Ltd is a leading supplier and manufacturer of Intermediate Building Blocks and Research Chemicals to the global R&D and Pharmaceutical market. We list a wide range of Fluorochemicals, Organic Intermediates, Biochemicals, High purity Inorganics and Spectroscopy consumables. In addition to our catalogue business we offer custom synthesis from our UK based lab.

Aquitaine Science Transfert is the Technology Transfer Office for the south west of France, covering 5500 researchers and 135 laboratories. We represent the regional academic research labs: Bordeaux University, INSERM, CNRS, Pau University, Bordeaux Polytechnic Institute… Since our creation in July 2012, we have signed 48 license agreements, patented 285 technologies and created 17 startups. Health, wellness and medical devices represent a key business in which our company is highly involved.

The “Association Française des Sociétés de Services et d’Innovation (AFSSI)”, French Association of Outsourcing and Innovative Companies in the field of Life Sciences was born in 2012 to gather companies established in France and providing R&D services to industrial or academic partners.
AFSSI represents over 130 companies involved in a dual business model, investing a significant part of their revenues in R&D to update and broaden their technology offering in order to run research programs.

Atlanpole Biotherapies is a competitiveness cluster involved in the medicine of tomorrow. It is focused for the development of new therapies, immunotherapy, regenerative medicine and radiopharmaceuticals, on the bio-medicine value chain from target discovery to clinical evaluation, completed by digital and nutrition approach. The projects of our network of 235 members, both academic and industrial, show the excellence of our expertise in personalized medicine.

AxLR is a technology transfer acceleration company. Our specialty is helping innovative projects derived from academic research reach maturity and commercialization. We work with the main public-sector research laboratories in France’s Mediterranean area in Occitanie, one of the most dynamic locations in Europe, with over 200 laboratories and some 12,000 researchers.

Baccinex is a Swiss based fill&finish CDMO specialized in development and manufacturing of sterile & lyophilized clinical material for pre-clinical, Phase I, II and III as well as commercial supply batches.
Our expertise is forged by 15 years of sterile clinical and commercial material manufacturing.
We are a one-stop flexible structure CDMO with a batch size from 500 to 12’000 vials on one production line. We also propose in-house sterile ampoules manufacturing.

Biogenouest combines expertise, capability and equipment through a network. Our team strive to develop technology’s platforms drawing on a coordinated approach and on various funding streams and enable all the scientific community (labs and business) to gain access to the services and resources. The network brings together 34 technology core facilities about Genomics, Proteomics, Fonctional exploration, Bioimaging, Structural & Metabolomics analysis, and Bioinformatics.

BioPartner UK is the accredited trade organisation that provides practical support and international promotion to UK Life Sciences companies, who wish to grow their business overseas. BioPartner signposts to UK expertise and leads delegations to promote the UK presence at major international biopharma conferences. By operating in partnership with the UK government and event organisers, BioPartner assists all UK companies with access to government grants and heavily discounted entry fees.

BlueReg – Your regulatory partner to Europe and beyond
BlueReg is a consulting company offering strategic regulatory advice to life sciences companies. We provide flexible solutions or operational platforms to meet your company’s needs from product development, registration through to launch & product maintenance activities.
Our internal experts are committed to support biotech and pharma companies with the best scientific & regulatory advice to transform innovation into a successful product.

Carakters is a boutique innovation-focused law firm based in Paris. By using original methods (results chart, risks mapping), Carakters works as project manager for life sciences actors leading innovative projects in drug discovery, connected devices and biotechnologies, with a focus on public-private consortia, industry-academia collaborations and technology transfers. Carakters also acts as R&D contract manager and offers its clients risks assessing tools to protect their confidential assets.

Ciloa is an exosome-based R&D power house that customize exosomes to contain any chosen proteins embedded in their membrane & inside their cytosol. Exosomes are naturally tailored in vivo by cells and membrane proteins complexes are sorted with their fully native conformation.
Natural properties of exosomes combined with Ciloa disruptive technology allow to develop I) antibodies against challenging targets; II) exosome-based therapeutic vectors; III) virus & adjuvant free vaccines

With nine facilities located in France, Canada, the US, Denmark and Hungary, Citoxlab offers a comprehensive range of preclinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies. Citoxlab carries out studies in general and reproductive toxicology, immunology, pharmacology and preclinical and clinical bioanalysis/biomarkers. With Solvo joining the Group, products and services in the field of transporters and DDI are now available.

FINDMED is a consortium of French academic Carnot institutes devoted to human and animal Health. Covering the whole R&D value chain, its role is to support Small Medium-sized Enterprises development by facilitating access to academic research and technological resources. It gathers 7 leading institutes in Health (Vision institute, Institut Pasteur, Institut Curie, ICM, INRA, CALYM, Imagine) and 5 more in chemistry, formulation and digital (Chimie Balard Cirimat, I2C, M.I.N.E.S, Smiles, TN@UPSaclay).

CzechInvest, the investment and business development agency of the Ministry of Industry and Trade, works with businesses based in the Czech Republic to support their development and encourages overseas companies to look at the Czech Republic as their partner of choice. The agency helps its Czech and international customers by providing services that range from information provision and consultancy to implementation of business development programmes.

The Interreg 2 Seas project DERMA aims to develop new interventions for the management and treatment of dermal ulcers and related skin conditions. By addressing market and patient need, the project will deliver advanced technologies ready for exploitation by industry to manufacture improved products for the treatment of patients. The objectives are to design, develop and evaluate an odour-absorbing, antimicrobial wound dressing and a dressing with diagnostic capability to indicate wound status.

DIVERCHIM CDMO is a dedicated manufacturer of Active Pharmaceutical Ingredients required in small quantities (From tens of grams up to hundreds of kilograms).
Based on its expertise in terms of chemical synthesis as well as documentation and regulatory aspects for commercial API manufacture, DIVERCHIM has developed over the last years its offer for pre-clinical and clinical needs for biotech and pharma companies.

DRUGABILIS is an established CRO specialized in pharmaceutical drugability of R&D compounds, including cytotoxic drugs. Our expertise includes API Solid Form Optimization (salts, polymorphs, cocristals) & Early Formulation, ranging from animal formulation (efficacy, PK, Tox) to early clinical formulation feasibility assessment (oral low soluble, injectable, ocular, dermal, vaginal …). Our recent relocation to new facilities allowed us increasing our capacities for new projects and clients.

e-Zyvec is your new expert in DNA vector design and production. Using our proprietary DNA assembly technology we modularly assemble any kind of vector to fit your specific requirements. We provide our services for genome editing, protein or cell engineering, multiple gene expressions. We can also handle any custom demand in vector creation. You design your experiment, we create the fitting tools. We are here to set your scientific ingenuity free!

Enterprise Lithuania is a non-profit agency under Ministry of Economy established to promote entrepreneurship, support business development and foster export. Their mission is to support the establishment and development of competitive businesses in Lithuania and to foster the country’s exports by facilitating cooperation with partners’ networks and providing quality training, consultancy, market analysis, and business-partner search services.

The EU-Japan Centre for Industrial Cooperation is a unique venture between the European Commission (DG GROW) and the Japanese Government (METI).
The EU-Japan Centre manages matchmaking missions, information seminars and researches, managerial training courses, student placement programmes and other services all designed to help bring European and Japanese businesses together.

Eurasanté is an incubator, a technology transfer tool and a cluster manager all at once, in the biotech, medtech, nutrition and healthcare fields in Northern France. It helps French and foreign companies, entrepreneurs, scientists and clinicians with their innovation and development projects.

The regional network includes more than 1,000 companies working in the Life Sciences and Healthcare fields. The Health field in the Hauts-de-France region has a total of 28,000 employees.

Founded in 2009 by regional stakeholders, EUROBIOMED is the Life Science cluster from Southern France. We gather more than 250 innovative biotech and medtech companies, as well as leading research institutes, hospitals and universities. We lead territorial initiatives and help our members businesses and research organisations to innovate, finance, develop and achieve their scientific and business objectives, to ultimately improve the treatment and the lives of patients.

Eurobiomed tops European rankings in all stages of innovation: education, basic, translational and clinical research, technological innovation centers, start-ups and industrial success stories. Some of Eurobiomed main assets are the number of people involved, but also the quality of the network and trust that is established between its members, which reinforces the interactions and facilitates collaborations.

Our missions:

• Develop the Life Sciences network activity in the South of France (Animation of the innovation community, matchmaking and networking between members, organisation of more than 25 scientific and business events each year, advocacy to third parties (public authorities, international stakeholders), etc. ).
• Structuring public-private R&D projects to get funded (Monitoring calls for projects, Identification of public and private partners, Support for project building and financing, Project follow-up until market access).
• Personalised support for life sciences companies growth (Corporate strategy, Fundraising, Business development and international markets, Regulatory compliance, Industrialisation and production, Acceleration programmes, Open innovation programmes, etc.).

Our business areas are new therapeutics, medical devices, diagnostics & Imaging and Digital Health.

Eurobiomed is the leader of the European Diagnostic Cluster Alliance and is the first immunology cluster in Europe.

FGK Clinical Research GmbH is a Europe-based full service Contract Research Organization with offices in Germany (HQ), Poland, Czech Republic, Hungary and UK. We provide full service for Phase I – IV clinical studies. FGK has the right size to handle multi-country, multi-center studies with hundreds of patients or single country studies with a few patients, but is still small enough to guarantee a personal service to the sponsor.

Firalis is a biotechnology company with a mission to improve disease outcome, therapeutic decisions and generate savings in healthcare through biomarker discovery, development and regulatory qualification that ultimately leads to biomarker-based diagnostics. Firalis develops and markets RUO (Research-use-only) and IVD (In-vitro-diagnostic) kits in the field of cardiovascular, inflammatory, autoimmune and neurology disorders.

GEMFORLAB is a scientific service provider devoted to supporting companies belonging to the Life Sciences field. GEMFORLAB services are aimed to solve problems linked to quality, safety, efficacy of products/ compounds subjected to development phase and to identify customized solutions to specific R&D issues.
Thanks to its scientific platforms, the quality system, the competences and the versatility of the team to meet customer needs, GEMFORLAB is the partner of choice of company which requires the capability to manage and solve complex problems following regulatory requirements.

Expertise in genomics and bioinformatics

GenoScreen, pioneering company in genomics and bioinformatics, has developed a portfolio of activities devoted to DNA molecule exploration and exploitation.

– Multi-specialist provider serving academic and industrial R&D

– Laboratory of high precision analyses and tests in genomics and microbial metagenomics

– A trusted partner to facilitate and accelerate R&D projects

– Provider of solutions and tools dedicated to the microorganism’s detection and analysis

GeT-IT provides genomics services based on the knowledge and expertise of the French National Institute for Agricultural Research (INRA). Our service allows us to offer multi-technology approaches to answer some biological questions. We are able to perform the complete workflow in-house from the samples to the data analysis thanks to our own instrumentation (rapidity and flexibility) and thanks to a team dedicated to industrials and private companies.

HCS Pharma provides services in pre-clinical in vitro research in high content cell imaging (HCS/HCA).
Expertise:
– In vitro tests in pharmacology & toxicology in 2D & in 3D culture in medium / high throughput.
– BIOMIMESYS® (proprietary technology for 3D cell culture): unique, natural & versatile scaffold based on hyaluronic acid, biofunctionalized with other extracellular matrix components.
Onco-Neuro-Hepato-Adipo-Dermato- Microbiota-Antibio -Tox-quantitative Imaging – Human & animal Health

Hirsch & Partners is an Intellectual Property law firm set up in 1968 providing worldwide full IP services (patent, trademarks, copyright, designs & licensing), allowing clients to meet their intellectual property needs.

ID2Santé is a technology innovation centre operating in the Bretagne region (Western France). It is also the regional representative of the Atlanpole Biotherapies competitiveness cluster.
It is in close contact with regional researchers and companies from the health sector and helps forge partnerships to support R&D projects and to develop innovative health products.

IDF Innov is a private TTO with exclusive rights on technology detection, seeding and commercialization over a vast academic territory in the Paris Metropolitan Area. This territory is strong of more than 20000 researchers, clinicians and PhDs, and hosts the strongest cluster for clinical expertise in France.
IDF Innov operates as a seeding funds and is committed to facilitate the due diligences for IP related private-public partnering and start-up creation.

Immune insighT is a CRO which carries ex-vivo and in-vivo preclinical assessment of new active molecules on the immune system in the fields of Cancer, Autoimmune and Inflammatory diseases. Immune Insight has a strong expertise in Treg full analysis but provides also a full range of services including phenotypic, metabolic, functional, recruitment and conversion analysis of several other human immune cells (monocytes, NK, macrophages, B and T cells, Neutrophils…).

InBrain Pharma is a biotechnology start-up, spin-off from academic laboratory, developing innovative solutions against neurodegenerative diseases based on Brain Infusion. Brain infusion is the direct administration of drug inside the central nervous system. Controlled administration in the CNS allows a precise, continuous and targeted administration which increases the efficiency and the safety of the treatments. Our first patented technology is administration of dopamine for Parkinson’s disease.

As a private subsidiary of Inserm, Inserm Transfert manages economic and societal value creation and the transfer of knowledge from Inserm research laboratories to companies contributing to promote human health innovation.

https://technology-offers.inserm-transfert.com/

The CALYM Carnot Institute brings together 15 research teams specialized in lymphoma, first blood cancer. This academic consortium, without international equivalent, aims at accelerating innovation and its transfer in the lymphoma treatment and diagnosis through a unique R&D offering: from the identification of new biological targets to registration clinical trials.

The Chimie Balard Cirimat Carnot Institute provides companies with R&D support in Chemistry, Materials and Processes. We offer innovative solutions to our partners, drawing upon our expertise in green chemistry and processes and in materials with enhanced properties. The comprehensive coverage by our research groups and the access to four state-of-the-art technological platforms allows us to meet any challenge from the energy, health, cosmetics and transport industries.

Curie Cancer is built on the expertise of Institut Curie (3200 people), a leading comprehensive cancer center in Europe and a world-renowned hospital group. Curie Cancer offers to industrial partners the ability to setup research collaborations from therapeutic target identification to clinical validation.

Carnot Institute Livestock Industry for the Future provides R&D competences to livestock sector businesses, mobilizing three main levers for multiefficient, sustainable and profitable farming: health, nutrition and breeding systems and animal genetics. It brings together actors from agro-veterinary research from INRA and its academic partners with an international visibility and three Agricultural Technical Institutes leaders in the breeding services.

The ICM Carnot Institute is comprised of a research center, a center for clinical investigation and an incubator for start-ups dedicated to finding solutions for diseases and disorders of the central nervous system. Headquartered in a 22,000 sqm building equipped with the latest technological core facilities, our goal is to promote strong partnerships as a means to accelerate translational research and respond to industry actors unmet needs.

Composed of Armines and 8 engineering schools, the M.I.N.E.S Carnot Institute is built on a multi-disciplinary academic foundation enhanced by a 50-year heritage of providing solutions to meet the needs of the socio-economic players. Truly inspirational for companies seeking innovation, the M.I.N.E.S Carnot Institute draws its strength from its motivation to break down scientific barriers.

Through an interdisciplinary research and integrative approach, Pasteur MS, located at the heart of Institut Pasteur, Paris, aims to provide a better understanding of the fundamental mechanisms of host/ pathogen interactions and microbes’ impacts on human health. Its ultimate goal is to foster the development of innovative products, in partnerships with biotechnology and healthcare industries, in the therapeutic, diagnostic and vaccines fields.

Meeting consumer expectations with regards to the sensory and nutritional quality of foods as part of a sustainable food process is a major challenge in terms of innovation.

As such, the Qualiment® Carnot Institute implements scientific and technological resources required to support companies in their projects in the field of improvement and development of food products.

The Carnot SMILES is a public research institute which aims at making the most of the power of applied mathematics, through collaborative research, in order to foster innovation within companies. Made up of multi-disciplinary teams, the institute accompanies its industrial partners in their technological challenges regarding bioscience (among other themes): molecular dynamics simulation, growth of cells population modeling, wound healing modeling, protein-protein interaction, metagenomics.

The Institut Carnot Technologies Numériques @ UPSaclay (TN @ UPSaclay), spearheaded by List, an institute of CEA Tech, conducts smart digital systems R&D covering four main areas: Technologies for manufacturing, Cyber-Physical Systems, Data intelligence, Technologies for personalized medicine. At the crossroads of basic research and industrial R&D, this work addresses the field of information and communication science and technology.

The Voir et Entendre Carnot Institute represents one of the most important centers in neurosensory research. It harbors, aside from the research center, a clinical investigation center, a rare disease reference center and an incubator. The institute is designed as a place of exchange gathering on the same site patients, clinicians, researchers and industrials in order to accelerate technological innovations, while bringing solutions to unmet needs of people with visual and hearing impairments.

IPAZ is an intellectual property law firm committed to its clients, who they are and what and their business is. With an entire department fully dedicated to the health sector, specialized in Life Sciences and Biotech, we provide tailor-made solutions and IP services – prosecution, strategy & valuation – for building strong patent portfolios and thereby creating valuable assets.

For 40 years, IPSIDE has been a 100% focused on intellectual property, from the acquisition of rights to their defense and commercialisation. We transform your creativity into economic strength !
Based in France, the USA and China, our team of 80 employees offers holistic Intellectual Property strategies adapted to the needs of each of our clients.
Every year, we file about 1000 new patent applications in addition to thousands of trademark registrations around the world, for nearly 2000 clients.

The toxicology laboratory of Institut Pasteur de Lille, headed by Fabrice Nesslany, performs genotoxicity, mutagenicity, toxicity and endocrine disruptor assessment of many types of substances (human and animal drugs, cosmetics, chemicals, nanomaterials…), under GLP or in screening. Our experts advise you in the choice of the test protocols, the interpretation of the results and follow-up studies. The department is also implicated in national and European research projects.

Linksium selects and reinforces disruptive technologies generated by deep public research results in Grenoble Alps area. All funded projects have valuable intellectual property inside. At a glance, business players can easily discover and scout most promising technologies and startups that may be the next game changers of the market.

Linksium funded 115 technologies with 21 M€ over three years. 30% of its technologies portfolio (licenses or startups) push back scientific boundaries in health field, and specifically for medical devices.

MétaGénoPolis is a Centre of Excellence in Human and Animal microbiome using standardized high throughput DNA metagenomics analyses.
Our 50 years expertise is recognized worldwide thanks to the 80+ high impact publications of our researchers (S. D. Ehrlich,J. Doré,H. Blottière).
Our goal is to understand host-microbiome interactions. Our collaborations with health, pharmaceutical, food and animal industries enable the translation of the most recent discoveries into health-related products.

MethylDetect’s ApS, products help the researchers to study the biology and significance of methylation changes in disease pathology. Our ambition is to bring our technology into routine use in in-vitro diagnostics for early disease detection, disease risk assessment and personalization of the treatment.

Microsynth (founded in 1989) is a leading European company in the area of nucleic acid synthesis & analysis. The main activities are divided into following three business areas:
DNA/RNA Synthesis
DNA/RNA Analysis and Sequencing
Contract Research/Outsourcing

For almost three decades, the company’s objective has been to serve its customers by delivering products and services of the highest quality, on time and with outstanding service.

Mitologics is an innovative biotechnology company specialized in detection of mitochondrial dysfunctions. The company offers compound screening services on healthy and pathological mitochondria and cultured cells: predictive toxicity assays (MiToxView® and SeaHorse®) to detect mitochondrio-toxic compounds presenting risks in human; efficacy assays to identify tumor specific-compounds and their MoA (MitoPathway®); mitochondrial targeting assays (protection against oxidative stress; MitoXpert®).

NeurATRIS is a French translational research infrastructure dedicated to translational neuroscience and aimed at validating new treatments / biomarkers for neurodegenerative diseases.
NeurATRIS gives access to its world-class preclinical / clinical facilities and cutting-edge equipment (neuro-imaging, biotherapy, cell and animal models, behavior, aptamers, etc.) to life science actors through a one-stop shop.

Neuro-Sys is a French pharmacology company that relies on the expertise and experience of pharmacists and pharmacologists specialized in the R&D of molecules used to treat neurodegenerative diseases such as AD, PD, HD, ALS…
It is specialized in in vitro screening of neuro active molecules and mode of action research.
Neuro-Sys is a privileged partner in the pharmaceutical industry and for biotechnological companies developing neuroprotective and neurorehabilitation molecules.

We want to make impact on healthcare, so only the best healthtech innovations lead to a NLC spin-off. We bring together the best tech, the best people, and the best capital to bring healthtech to the patient. We designed a model to create early stage healthtech ventures. We work with leading European research institutes, first-class hospitals, successful entrepreneurs, world-class capital, innovative SMEs, global market leaders, and the whole range of service providers. We bring science to life!

Nova manufactures automated analyzers for cell culture and fermentation monitoring. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Our modular BioProfile FLEX provides key chemistries and gasses and is expandable to include Cell Density and Cell Viability, Osmolality, and IgG or Ph or Phosphate results with the same sample and a single data output stream.

The Nutrition Health Longevity (NHL) Cluster is a dynamic network at the intersection of health, biotechnology and nutrition. The NHL Cluster aims to connect academia and industry partners around R&D projects. It focuses on the fields of prevention and treatment of lifestyle related diseases, such as metabolic and cardiovascular pathologies, neurodegenerative diseases and inflammatory bowel diseases. Its goal is to gather and support players from the health and food sectors in designing, developing and financing their future products and processes.

Open R&D Lithuania network is a platform of cooperation between open access R&D centers of 14 Lithuanian Universities, 13 Public Research Institutes as well as 7 Science and Technology parks. Six of these institutions specializes in Life Sciences and Biotech area and has modern R&D facilities and close collaboration between scientific and clinical units. Concentration of resources allows to create new technologies and products as well as provide R&D services.

Original Process, specialist of the health of the animals digestive microbiotia for 40 years.
From its own technology FAP®, Original Process develops exclusive Processes for unique ProbioactiFAP ® products, naturally rich in prebiotic and postbiotic, for a better digestive Health and immunity. Original Process proposes its R&D and regulatory services to the distributors (vet and feed) and produces as well on its own brand name as under private label. For the design product and the evidence efficiency, Original Process develops and pursues its studies (in vitro, preclinical and clinical trials) in collaboration with scientific, medical and vet partners.

Ouest Valorisation – Office of Technology Transfer (OTT) was created in the “Future Investments” project call managed by Ministry of Higher Education and Research.

Its aim: to propose to companies attractive innovation means from the public research.
Ouest Valorisation’s team simplifies the access of the companies to research laboratories in order to develop good collaborative projects or to get access to high professional skills and high level scientifical equipment.

Par’Immune is a French company leveraging 20 years legacy of academic research on a parasite-derived protein, P28GST, to develop therapeutic strategies toward aggressive inflammatory autoimmune diseases.
Besides its safety profile validated in several clinical trials, the immunomodulatory potential of P28GST has been demonstrated in preclinical models of inflammatory diseases. Our drug candidate is under evaluation in a Phase 2a clinical trial in Crohn’s disease.

PharmaLex is one of the most experienced providers for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Vigilance, Epidemiology & Risk Management activities, associated with medicinal products and medical devices.
Our global teams of experts will take you from early strategic planning and CMC/NC activities to clinical development, via regulatory agency advices towards market approvals and/or product maintenance support.
Please come and visit us at our booth A6

Picomto provides web and mobile solutions to help pharmaceuticals companies to digitize their Work Instructions and Standard Operating Procedures in compliance with GMP and FDA Standards (21 CFR Part 11). This is a digital and connected tool for making sure your operators have taken into account the latest version of SOP/WISOP to increase your audit trail level. It ensures your processes to be secured, repeatable and allows you to track all the operations with field data collection.

PMC Isochem offers contract research, custom manufacturing and catalogue products for Pharmaceutical companies worldwide. Our offer addresses three areas:
– CDMO services: GMP industrial exclusive custom synthesis and provides tailor made services from development to production, including route selection.
– Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polypeptides based solution for Nano Encapsulation and Polymer Drug
– Generic APIs: 20 generic API

Polepharma is the first pharmaceutical alliance in Europe, covering 3 regions (Centre-Val de Loire, Normandie and Ile de France) that ensures 53% of drug production in France. Its network relies on a team of experts who aim at stimulating industrial and economic development of the pharmaceutical industry with actions that promote competitiveness, innovation, attractiveness and the “Made in France”.

Porsolt, a long established, AAALAC accredited and fully GLP compliant, preclinical CRO, has been providing efficacy and safety pharmacology services for over 30 years, covering the drug development process from early screening thru regulatory submission.
Porsolt provides in vitro assays (high throughput screening, high content analysis, and high content histology) and physiopathological models in multiples species and multiple disease areas, tailored solutions and bespoke model development.

PULSALYS is a French Technology Transfer Office (TTO), created in 2013 with a public funding of 57 M€, committed in detecting high-potential research results from the laboratories of Lyon & St Etienne, and turning them into strong innovations for companies, or into high tech startup businesses.

RD-Biotech is a French CRO offering a wide range of custom services and products in Biotechnology:
Bioproduction & purification: Monoclonal and recombinant antibodies (murine, rat, humanized, Fab, ScFv …) Recombinant proteins, Plasmids, cells.
Development: Hybridoma, transfection and cell lines, Vector, Chimeric and Humanized antibodies, phage display (mouse, llama)
Analytical services: Immunoassay, OCTET, bioassay
FastELISA kits: IgG quantification (mouse, human, rat), Protein A detection.

In France, SATTs have the challenging mission to accelerate the transformation of French research into innovations. Their aim is to enhance the value and to accelerate the process of technology transfer from publically funded research toward industry. SATTs evaluate, market and license technology from French Universities and Public Research Organisations.

SATTs have become a major actor of economic development to reinforce company competitiveness, with an emphasis on SMEs and start-ups.

Roowin is a privately owned Contract Research Organisation (CRO) headquartered in Riom (Auvergne), France. Its core business being in high value added fine chemistry, Roowin offers a large range of chemical services.

We support our customers and partners to advance their drug candidates from early research phase up to licensing out API in phase II or to the Market for small batches (about 20 kg).

salamanderU regenerates conventional practices in regenerative therapies market with a tailor made approach:
– ATMP production unit: salamanderU engineers, designs, builds, installs and maintains your facility & Mobile units (lab in a truck or clean room fully integrated in container)
– Voice Electronic Batch Record: Increase your productivity & reduce risks with Smartreg
– Isolator systems: Synthetic resin isolator for aseptic confined operation
– Quality Management System: Achieve your QMS & Consultancy

SATT Nord is a growth-generating tool for valorisation serving researchers and responding to the economic and societal needs for technology transfer. Thanks to a multidisciplinary team of professionals (experts in the various fields of research, project managers, experts in intellectual property, legal experts), SATT Nord ensures the detection of projects, their maturation and the protection of the intellectual rights and even up to their commercialisation through transfer.

SATT Sud-Est is a key player in regional economic development associated with innovation. Its core business – technology transfer – consists of protecting, developing and licensing the results of research from public laboratories in the South & Corsica Regions to the socio-economic world. Its goal is to help companies acquire reliable innovations that are better suited to the industrial challenges they face.

Sciomics offers a high-content analysis services for combined phosphorylation / ubiquitinylation and protein analysis to investigate pathway activity, disease mechanisms, drug mode-of-action or discover novel drug targets and biomarkers.
Currently, more than 1,000 proteins, many being keyplayers in biomedical pathways are analysed in parallel by our immuno-based antibody array platform. The platform guarantees robust and reproducible results which can easily be translated in clinical assays.

SIMV – French association of animal health industry
The French association for animal health industry (SIMV) represents and federates 40 manufacturers and marketers on the French market of medicines and reagents for pets and for farm animals.

SMALTIS is a CRO specialized in Microbiology and Molecular Biology. By constructing genetically modified bacteria and providing scientific and technical services to understand the characteristics and mechanisms involving microorganisms we help our clients to accelerate the development of their biological products and drugs. Our areas of expertise are the development of new anti-infective compound, the study of microbiota and the setting-up of tools and methods for Bioproduction process.

Soladis is a consulting and service company specialized in health data.
We developed our expertise on the three challenges of data :
– collection and storage (through IoT, sensors, biosensors, CRF/eCRF, surveys,…),
– processing and analysis (data management, statistics, biostatistics, data science, machine learning),
– valorization (clinical reports, dashboards, data visualisation, algorithms,..).
Our CRO team can also support pharma, biotech, MD-IVD…clinical studies from A to Z.

European IP Attorneys, experts in patents, trademarks, and all other intellectual property rights, in terms of acquisition, exploitation and defense, in your country, in Europe and internationally.

We may also assist you to remove technological barriers and optimize your production based on technical information interallia from non-enforceable patents.

The associated Carnot I2C brings together 8 research entities from Normandy on the 2nd territory of the chemical industry in France. With a strong expertise in synthesis, analysis and formulation, I2C capitalizes on this chemistry value chain as a privileged partner to support innovation for the pharmaceuticals, fine chemicals, food, bioresources, cosmetics, energy and environmental sectors industries.

Within Necker-Enfants malades Hospital in Paris, Imagine Associated Carnot’s brings together a large number of genetic diseases’ specialists with the aim to better understand these disorders to better diagnose and treat them. Its patient-centered organization and the close collaboration between clinicians and researchers implement a unique translational model that facilitates research collaborations and the establishment of new therapeutic strategies with the industrial partners.

Research, collaboration and innovation that’s transforming our world for the better. Our researchers work with industry partners from discovery science across the translational spectrum, to improve patients’ lives and positively impact their care. We collaborate with the pharmaceutical, medical diagnostic and medical device sector, along with many biotech companies.

As a leading company, Xell provides highly-efficient solutions in cell culture technology. With a strong focus on cell culture medium and feed development, we have continuously strengthened our technology. In addition to a broad analytical portfolio, we offer customized formulations and high-performance catalog products for CHO, human and Hybridoma cells including special applications (e.g. transfection, virus production): Chemically defined, animal origin-free and suitable for GMP applications.

Xpress Biologics is a contract development organization specialized in the production of Biologics (proteins, antibody fragments and DNA) for preclinical applications specific to the therapeutic, vaccine and diagnostic markets.
Our mission is to enable the transition of projects from R&D to clinical manufacturing.
The production scale (from 100 mg to 50 g) and the quality of the biologics (R&D and GLP grade) are adapted for in vitro and in vivo preclinical validation of the biologics.

Xprochem specializes in the chemical synthesis of complex proteins (up to ~400 a.a.) that cannot be produced by recombinant methods or are too difficult to synthesize or purify with an acceptable yield. We can also include a variety of finely targeted substitutions, i.e. glycosylations, pegylations and unnatural amino acids.

The Chair Digital System & Life Sciences is created to foster the translation of innovative technology in biology and medicine towards original approaches for early diagnosis and patient monitoring for several pathologies. Within Eurasanté, the Chair represents a stimulating ecosystem for start-up development, relying on expertise in BioMEMS (Miniaturized system for biology and health) and Artificial Intelligence. Yncréa and SMMiL-E cross their expertise to launch the chair during Biofit event.

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales in more than 100 countries.